Fourteen women with normoprolactinaemic amenorrhoea were treated with bromocriptine (2.5 mg twice daily) for a period ranging from 4 to 17 weeks, while a matched group of 19 amenorrhoeic women were treated with a placebo (one tablet twice daily) for 4 to 12 weeks. About half of the patients in both groups had at least one episode of vaginal bleeding during treatment. There was no clear difference in the menstrual and ovulatory pattern between placebo and bromocriptine groups.
Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea / P.G. Crosignani, E. Reschini, G.C. Lombroso, M. Arosio, M. Peracchi. - In: BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY. - ISSN 0306-5456. - 85:10(1978 Oct), pp. 773-775.
Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea
P.G. CrosignaniPrimo
;M. ArosioPenultimo
;
1978
Abstract
Fourteen women with normoprolactinaemic amenorrhoea were treated with bromocriptine (2.5 mg twice daily) for a period ranging from 4 to 17 weeks, while a matched group of 19 amenorrhoeic women were treated with a placebo (one tablet twice daily) for 4 to 12 weeks. About half of the patients in both groups had at least one episode of vaginal bleeding during treatment. There was no clear difference in the menstrual and ovulatory pattern between placebo and bromocriptine groups.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
